Analysts who follow Oramed Pharmaceuticals, Inc. (ORMP) on average expect it to gain 675.86% over the next twelve months. Those same analysts give the stock an average rating of Hold. That average rating earns ORMP an Analyst Ranking of 6, which means it ranks higher than 6 of stocks, based on data compiled by InvestorsObserver.
Why are Analyst Ratings Important?
Analytical research by professionals can be extremely useful when making investment decisions in the stock market. Analysts are able to observe industries in detail and learn how geographical impacts can affect a company’s balance sheet. This information allows investors to make decisions ahead of the curve. InvestorsObserver combines the ratings from these analysts and proceeds to percentile rank them. This grants you the ability to compare stocks in a comprehensive fashion as oppossed to a standard buy/hold/sell rating.
What’s Happening With Oramed Pharmaceuticals, Inc. Stock Today?
Oramed Pharmaceuticals, Inc. (ORMP) stock is lower by -1.7% while the S&P 500 has gained 0.39% as of 9:49 AM on Monday, Jan 23. ORMP has fallen -$0.03 from the previous closing price of $2.06 on volume of 276,771 shares. Over the past year the S&P 500 is down -9.57% while ORMP has fallen -77.09%. ORMP lost -$1.04 per share the over the last 12 months. Click Here to get the full Stock Report for Oramed Pharmaceuticals, Inc. stock.
Subscribe to our daily morning update newsletter and never miss out on the need-to-know market news, movements, and more.
Thank you for signing up! You’re all set to receive the Morning Update newsletter
Stock Price data may be delayed up to 15 minutes.
Copyright © 2023. Portions of this content may be copyrighted by Fresh Brewed Media, Investors Observer, and/or O2 Media LLC. All Rights Reserved. Portions of this content protected by US Patent numbers 7,865,496, 7,856,390, and 7,716,116. Investing in stocks, bonds, option and other financial instruments involve risks and may not be suitable for everyone. Portfolio results are unaudited and based on varying investment expiration dates. Terms of Service | Privacy Policy
